Skip to content

Clinical trials

Terminated Cardiovascular Diseases trials in Canada

Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.

Filters: Condition: Cardiovascular Diseases Status: Terminated Country / region: Canada Clear all

25 trials match Source: ClinicalTrials.gov registrations

Trials started per year

By phase, 2000 to 2026.

Trials started per year
CategoryTrials
20021
20031
20041
20052
20061
20071
20082
20102
20111
20122
20132
20163
20171
20182
20191
20201
20221

Status

Trials by registry status. Select a bar to filter.

Trials by status
CategoryTrials
Terminated25

Top lead sponsors

A sponsor with a page on Pharma Observatory links to it.

Top lead sponsors
CategoryTrials
London Health Sciences Centre Research Institute OR Lawson Research Institute of St. Joseph's2
Pfizer2
University of Manitoba2
Amgen1
AstraZeneca1
Axio Research. LLC1
Cardurion Pharmaceuticals, Inc.1
Dr. Graeme Smith1
Eli Lilly and Company1
Forest Laboratories1

Top conditions

MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.

Top conditions
CategoryTrials
Cardiovascular Diseases25
Stroke5
Heart Diseases4
Myocardial Infarction4
Diabetes Mellitus3
Hyperlipidemias3
Atherosclerosis2
Diabetes Mellitus, Type 22
Heart Failure2
Obesity2

Trials

Showing 1 to 25 of 25. Each trial links to its page on Pharma Observatory.

Recently changed trials

Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.

No changes to these trials in the last 7 days.

Go deeper on Pharma Observatory

Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.